How blood cancer treatment is evolving in the Middle East

This week on the Podcast, we are joined by Dr Amr Hanbali.During Blood Cancer Awareness Month, Guy Martin, news editor at The Pharma Letter, sat down with Dr Hanbali to discuss his experiences treating patients with CAR T-cell therapy in the Middle East.With extensive experience in hematology and the treatment of blood disorders such as leukemia and myeloma, Dr Hanbali has been closely involved in expanding access to advanced therapies across the region.Dr Hanbali discussed the evolution of blood cancer treatment in the Middle East, the unique challenges patients face in accessing cutting-edge therapies, and how CAR T-cell treatments are offering renewed hope for long-term remission.He also shared his personal reflections on the impact of this therapy on patients and families, what needs to happen to improve regional access, and his vision for the future of blood cancer care in the next decade.